by Thomas Lethenborg | Mar 4, 2021 | News
Since the EcoWeB project launched MyMoodCoach (an app powered by Monsenso) in November 2020 it has recruited more than 1600 young participants in Belgium, UK, Spain and Germany.
The EcoWeB research study, led by Professor Ed Watkins University of Exeter, seeks to understand what influences mood, how emotions change over time, and which emotional skills increase well-being among youth.
The participants are asked to use MyMoodCoach to monitor their emotions in daily life, while giving them access to “Tools” and “Challenges” to boost their mental health and wellbeing. ‘Tools’ provide the participants with strategies to help them if they feel sad, stressed, anxious or have a problem. ‘Challenges’ help them to learn new skills, develop a positive mindset, improve their confidence and gain insight into their emotions.
The strong pick up of MyMoodCoach reflects a desire among youth to take better care of their mental wellbeing.
“We are very pleased to contribute to this project, as young people have been particularly impacted by COVID-19.” says Thomas Lethenborg, CEO of Monsenso. “Mobile health solutions have proved true value during the pandemic, allowing both clinical practice and important research projects to continue despite lockdowns.”
About the project:
The EcoWeB project is led by Professor Ed Watkins, University of Exeter, and involves 13 different institutions across 8 European nations (the UK, Germany, Belgium, Spain, Greece, the Czech Republic, Denmark, and Switzerland). The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 754657.
About Monsenso digital health solution:
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and health care providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our endeavours to deliver solutions that fit into the life of patients and health care professionals. To learn more visit www.monsenso.com.
by Thomas Lethenborg | Mar 25, 2019 | News
Copenhagen, Denmark – 25 March 2019. The University of Exeter, supported by the South West Academic Health Science Network, has partnered with Danish mobile health provider Monsenso in ‘The MOVE Study’ (formerly known as The Klick Project), a research project that aims to review how the Monsenso Solution can be used to support individuals to engage in healthy behaviours that could make a difference to their risk of getting dementia. The Monsenso Solution is a mobile platform, where the individual is prompted with daily self-assessments, weekly clinical scales, while sensor data is collected via the phone. Moreover, it connects the individual and clinician, visualising individual-reported data for both parties and facilitates the possibility of providing patients with relevant information to handle specific challenges that may impact their wellbeing.
Both from a societal and a clinical standpoint, the burden of dementia is a growing challenge. The number of people affected by dementia worldwide will reach 75 million people in 2030. In the UK, for example, Dementia UK estimated that approximately 850,000 people were living with dementia[1]. In addition, it was estimated that one in three people born in 2015 will develop dementia in their lifetime[2]. Therefore, new ways of tackling this challenge must be found.
In collaboration with Monsenso, the lead researchers on The MOVE Study – Dr Barbora Silarova and Dr Rachel Collins will set up the solution to support The MOVE Study, and hereafter demonstrate its capabilities for clinicians and patients and receive their feedback. The findings will be used to guide development of future intervention that focuses on changing healthy behaviours that could make a difference to people’s risk of getting dementia. It is planned for the intervention to be delivered in primary care. The configuration of the Monsenso Solution for The MOVE Study will include one of the newest additions to the system; an integration to Withings (wearable technology) which allows for collection of sensor data, such as physical activity, sleep and pulse.
Thomas Lethenborg, CEO of Monsenso, says: “Dementia is a huge challenge for society to overcome, and it will be growing in the coming years due to an ageing population. We are looking forward to testing whether our solution can help people to engage in healthy behaviours to live a healthy life. We may draw on experiences gained from the H2020 funded WellCo project, which aims at improving the well-being of elderly people.”
About
University of Exeter
University of Exeter
combines teaching excellence and high levels of student satisfaction with world
class research at their campuses in Devon and Cornwall. They are part of the
Russell Group as one of the 24 leading UK universities. Their success is
built on a strong partnership with their students and a clear focus on high
performance.
For more information about dementia research conducted at University of Exeter, please see http://www.exeter.ac.uk/dementia/.
About
South West Academic Health Science Network
The South West Academic Health Science Network (SW AHSN) works to improve the health and patient experience of people in the South West by supporting and accelerating innovation and quality improvement. SW AHSN is part of a national network of 15 AHSNs set up by NHS England, to identify, adopt and disseminate innovative healthcare. As part of KLICK, they will be aiding in the conversation and co-design of solutions to better meet patient needs by bringing together innovators and adopters of new ideas for health and social care.
To learn more, visit https://www.swahsn.com/.
About
Monsenso
Monsenso is an innovative technology company offering a mHealth solution that optimises the treatment of mental disorders. The smartphone-based solution gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data, and it connects individuals, carers and health care providers enabling personalised treatment, remote care and early intervention.
To learn more, visit www.monsenso.com
For
more information about Monsenso contact:
Thomas Lethenborg
CEO
Monsenso
+45 21298827
lethenborg@monsenso.com
[1] Dowrick, A.,
Southern, A. . Dementia 2014: Opportunity for change. 2014 17/10/2018]; Available from: https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/dementia_2014_opportunity_for_change.pdf.
[2] Lee, V.S., J. Simpson, and K. Froggatt, A
narrative exploration of older people’s transitions into residential care.
Aging Ment Health, 2013. 17(1): p. 48-56.
